Takeda Pharmaceutical Company Limited (4502.T)
JPY 4093.0
(-0.1%)
JPY 4093.0
(-0.1%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4843.75 Billion JPY | 10.53% |
| 2022 | 4382.34 Billion JPY | 0.85% |
| 2021 | 4345.41 Billion JPY | -6.26% |
| 2020 | 4635.37 Billion JPY | -8.99% |
| 2019 | 5093.3 Billion JPY | -11.44% |
| 2018 | 5750.95 Billion JPY | 483.46% |
| 2017 | 985.66 Billion JPY | -13.91% |
| 2016 | 1144.89 Billion JPY | 49.03% |
| 2015 | 768.22 Billion JPY | 5.33% |
| 2014 | 729.38 Billion JPY | -15.19% |
| 2013 | 859.98 Billion JPY | 54.17% |
| 2012 | 557.81 Billion JPY | -0.84% |
| 2011 | 562.56 Billion JPY | 3313.2% |
| 2010 | 16.48 Billion JPY | -12.35% |
| 2009 | 18.8 Billion JPY | -4.86% |
| 2008 | 19.76 Billion JPY | 238.95% |
| 2007 | 5.83 Billion JPY | -49.81% |
| 2006 | 11.61 Billion JPY | -7.69% |
| 2005 | 12.58 Billion JPY | -31.98% |
| 2004 | 18.5 Billion JPY | 26.4% |
| 2003 | 14.63 Billion JPY | 16.59% |
| 2002 | 12.55 Billion JPY | 5.18% |
| 2001 | 11.93 Billion JPY | -25.85% |
| 2000 | 16.09 Billion JPY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5480.98 Billion JPY | 13.16% |
| 2024 Q2 | 5051.19 Billion JPY | -7.84% |
| 2023 Q1 | 4747.11 Billion JPY | 8.32% |
| 2023 Q4 | 4843.75 Billion JPY | 3.85% |
| 2023 Q2 | 4679.2 Billion JPY | -1.43% |
| 2023 Q3 | 4664.16 Billion JPY | -0.32% |
| 2023 FY | 4843.75 Billion JPY | 10.53% |
| 2022 Q1 | 4602.25 Billion JPY | 5.91% |
| 2022 Q4 | 4382.34 Billion JPY | 2.23% |
| 2022 Q3 | 4286.9 Billion JPY | -9.49% |
| 2022 Q2 | 4736.64 Billion JPY | 2.92% |
| 2022 FY | 4382.34 Billion JPY | 0.85% |
| 2021 Q4 | 4345.41 Billion JPY | -0.22% |
| 2021 Q2 | 4231.35 Billion JPY | -3.96% |
| 2021 Q1 | 4405.86 Billion JPY | -4.95% |
| 2021 FY | 4345.41 Billion JPY | -6.26% |
| 2021 Q3 | 4354.87 Billion JPY | 2.92% |
| 2020 FY | 4635.37 Billion JPY | -8.99% |
| 2020 Q1 | 5074.95 Billion JPY | -0.36% |
| 2020 Q2 | 4908.03 Billion JPY | -3.29% |
| 2020 Q3 | 4751.04 Billion JPY | -3.2% |
| 2020 Q4 | 4635.37 Billion JPY | -2.43% |
| 2019 FY | 5093.3 Billion JPY | -11.44% |
| 2019 Q3 | 5221.75 Billion JPY | 3.92% |
| 2019 Q2 | 5024.61 Billion JPY | -11.11% |
| 2019 Q1 | 5652.64 Billion JPY | -1.71% |
| 2019 Q4 | 5093.3 Billion JPY | -2.46% |
| 2018 Q4 | 5750.95 Billion JPY | 125.64% |
| 2018 Q3 | 2548.78 Billion JPY | 154.74% |
| 2018 Q2 | 1000.53 Billion JPY | 0.56% |
| 2018 Q1 | 994.97 Billion JPY | 0.94% |
| 2018 FY | 5750.95 Billion JPY | 483.46% |
| 2017 Q1 | 1144.84 Billion JPY | -0.0% |
| 2017 FY | 985.66 Billion JPY | -13.91% |
| 2017 Q4 | 985.66 Billion JPY | -13.42% |
| 2017 Q3 | 1138.46 Billion JPY | 0.1% |
| 2017 Q2 | 1137.35 Billion JPY | -0.65% |
| 2016 Q2 | 951.26 Billion JPY | -0.33% |
| 2016 Q4 | 1144.89 Billion JPY | 17.32% |
| 2016 Q3 | 975.89 Billion JPY | 2.59% |
| 2016 Q1 | 954.4 Billion JPY | 24.24% |
| 2016 FY | 1144.89 Billion JPY | 49.03% |
| 2015 FY | 768.22 Billion JPY | 5.33% |
| 2015 Q4 | 768.22 Billion JPY | 5.22% |
| 2015 Q3 | 730.11 Billion JPY | 0.15% |
| 2015 Q2 | 729.03 Billion JPY | -0.56% |
| 2015 Q1 | 733.15 Billion JPY | 0.52% |
| 2014 Q3 | 912.87 Billion JPY | 3.72% |
| 2014 FY | 729.38 Billion JPY | -15.19% |
| 2014 Q1 | 855.91 Billion JPY | -0.47% |
| 2014 Q2 | 880.15 Billion JPY | 2.83% |
| 2014 Q4 | 729.38 Billion JPY | -20.1% |
| 2013 Q4 | 859.98 Billion JPY | 8.65% |
| 2013 FY | 859.98 Billion JPY | 54.17% |
| 2013 Q3 | 791.5 Billion JPY | 0.01% |
| 2013 Q2 | 791.41 Billion JPY | 46.11% |
| 2013 Q1 | 541.64 Billion JPY | -2.9% |
| 2012 FY | 557.81 Billion JPY | -0.84% |
| 2012 Q1 | 542.8 Billion JPY | -3.51% |
| 2012 Q4 | 557.81 Billion JPY | 2.94% |
| 2012 Q2 | 541.8 Billion JPY | -0.18% |
| 2012 Q3 | 541.87 Billion JPY | 0.01% |
| 2011 Q2 | 571.33 Billion JPY | 44887.01% |
| 2011 FY | 562.56 Billion JPY | 3313.2% |
| 2011 Q3 | 541.26 Billion JPY | -5.26% |
| 2011 Q1 | 1.27 Billion JPY | -92.29% |
| 2011 Q4 | 562.56 Billion JPY | 3.94% |
| 2010 Q4 | 16.48 Billion JPY | 414.9% |
| 2010 Q1 | 3.05 Billion JPY | -83.74% |
| 2010 Q2 | 2.99 Billion JPY | -2.16% |
| 2010 Q3 | 3.2 Billion JPY | 6.99% |
| 2010 FY | 16.48 Billion JPY | -12.35% |
| 2009 Q2 | 3.1 Billion JPY | 0.0% |
| 2009 FY | 18.8 Billion JPY | -4.86% |
| 2009 Q4 | 18.8 Billion JPY | 475.93% |
| 2009 Q3 | 3.26 Billion JPY | 5.29% |
| 2008 FY | 19.76 Billion JPY | 238.95% |
| 2008 Q3 | 3.69 Billion JPY | 0.0% |
| 2008 Q4 | 19.76 Billion JPY | 434.31% |
| 2007 FY | 5.83 Billion JPY | -49.81% |
| 2006 FY | 11.61 Billion JPY | -7.69% |
| 2005 FY | 12.58 Billion JPY | -31.98% |
| 2004 FY | 18.5 Billion JPY | 26.4% |
| 2003 FY | 14.63 Billion JPY | 16.59% |
| 2002 FY | 12.55 Billion JPY | 5.18% |
| 2001 FY | 11.93 Billion JPY | -25.85% |
| 2000 FY | 16.09 Billion JPY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 16.89 Billion JPY | -28576.526% |
| Sumitomo Pharma Co., Ltd. | 418.88 Billion JPY | -1056.347% |
| Shionogi & Co., Ltd. | 11.62 Billion JPY | -41584.613% |
| Wakamoto Pharmaceutical Co.,Ltd. | 100.52 Million JPY | -4818163.387% |
| Nippon Shinyaku Co., Ltd. | 2.87 Billion JPY | -168554.318% |
| Kaken Pharmaceutical Co., Ltd. | 3.85 Billion JPY | -125711.74% |
| Eisai Co., Ltd. | 206.74 Billion JPY | -2242.852% |
| Morishita Jintan Co., Ltd. | 425 Million JPY | -1139606.353% |
| Hisamitsu Pharmaceutical Co., Inc. | 2.1 Billion JPY | -230554.857% |
| Mochida Pharmaceutical Co., Ltd. | 369 Million JPY | -1312569.919% |
| Fuso Pharmaceutical Industries,Ltd. | 12.72 Billion JPY | -37973.825% |
| Nippon Chemiphar Co., Ltd. | 16.98 Billion JPY | -28424.539% |
| Tsumura & Co. | 79.69 Billion JPY | -5978.243% |
| Kissei Pharmaceutical Co., Ltd. | 1.72 Billion JPY | -280372.032% |
| Torii Pharmaceutical Co., Ltd. | 244 Million JPY | -1985044.262% |
| Towa Pharmaceutical Co., Ltd. | 202.35 Billion JPY | -2293.678% |
| Fuji Pharma Co., Ltd. | 28.94 Billion JPY | -16632.596% |
| Zeria Pharmaceutical Co., Ltd. | 47.58 Billion JPY | -10078.963% |
| KYORIN Holdings, Inc. | 20.94 Billion JPY | -23024.95% |
| Taiko Pharmaceutical Co.,Ltd. | 3.8 Billion JPY | -127065.975% |
| Daito Pharmaceutical Co.,Ltd. | 8.71 Billion JPY | -55453.986% |
| SymBio Pharmaceuticals Limited | - JPY | -Infinity% |
| MedRx Co., Ltd | - JPY | -Infinity% |
| Mizuho Medy Co.,Ltd. | - JPY | -Infinity% |
| Solasia Pharma K.K. | 60 Million JPY | -8072820.0% |
| Modalis Therapeutics Corporation | 412.5 Million JPY | -1174142.909% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 9.48 Billion JPY | -50967.496% |
| Sawai Group Holdings Co., Ltd. | 82.89 Billion JPY | -5743.59% |
| Cyfuse Biomedical K.K. | 913 Million JPY | -530431.435% |
| Toho Holdings Co., Ltd. | 30.24 Billion JPY | -15915.58% |
| Koa Shoji Holdings Co.,Ltd. | 2.82 Billion JPY | -171342.77% |